Abstract
Subacute oral administration of an experimental analgesic compound, l-2-(1-methyl-2-piperidyl)-1,1-diphenylethyl propionate hydrochloride, to four species of animals produced a variety of toxicologic responses. Rats tolerated oral doses up to 100 mg/kg/day for periods of 1 or 2 months without adverse clinicopathologic effects. Pregnant rabbits tolerated oral doses up to 80 mg/kg/day for 8 days during the period of embryogenesis without adverse effects upon either the doe or her offspring. In contrast, daily oral doses of 30 mg/kg or more produced emesis, weight loss, depression, unconsciousness, and, occasionally, death in both dogs and monkeys, and higher dosages usually caused death. Liver function was impaired in dogs but not in monkeys, although intracytoplasmic structures compatible with myelin figures occurred in the hepatocytes in both species. In addition, several monkeys had areas of demyelination in the brain which involved the white tracts of the cerebral gyri. These variations in response to a test agent reemphasize species differences and the difficulty in extrapolating toxicity data from one species to another. Because of the complexity of these findings, the compound was withdrawn from consideration as a candidate for clinical trials in man.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.